Trials / Completed
CompletedNCT02073461
Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.
A Multicenter, Randomized, Double-blinded, Vehicle-controlled Parallel Group Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 236 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study is to assess the efficacy and safety of two concentrations of CD1579 (2.5% and 5%) versus vehicle in the treatment of acne vulgaris in the Japanese patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CD1579 2.5% | |
| DRUG | CD1579 5% | |
| DRUG | Vehicle |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2014-02-27
- Last updated
- 2017-03-28
- Results posted
- 2016-11-03
Locations
6 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02073461. Inclusion in this directory is not an endorsement.